Witnessing the stock’s movement on the chart, on Thursday, Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) had a quiet start as it plunged -2.05% to $0.73, before
On Friday, Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) opened higher 5.88% from the last session, before settling in for the closing price of $0.74. Price fluctuations
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) open the trading on Wednesday, remained unchanged to $0.69, before settling in for the price of $0.69 at the close.
A new trading day began on Friday, with Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) stock price down -3.58% from the previous day of trading, before settling
Witnessing the stock’s movement on the chart, on Wednesday, Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) had a quiet start as it plunged -1.66% to $0.75, before
On Friday, Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) was -7.71% drop from the session before settling in for the closing price of $0.82. A 52-week range
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) kicked off on Tuesday, down -2.82% from the previous trading day, before settling in for the closing price of $0.96.
On Friday, Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) opened higher 11.84% from the last session, before settling in for the closing price of $0.89. Price fluctuations
Lexicon is heading towards a big breakthrough as the company obtains key primary endpoints in phase 3 of both the SOLOIST and SCORED studies. Lexicon
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
